Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3034 |
|
Actual shortage: | 241 (8%) | |
Anticipated shortage: | 18 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ELETRIPTAN | 40MG | TABLET TABLET | Resolved | 2020-09-02 | 2021-11-19 | 123558 |
APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2020-12-11 | 2021-01-11 | 130065 |
APO-CITALOPRAM | 40MG | TABLET | Resolved | 2020-12-18 | 2021-03-15 | 130401 |
APO-CITALOPRAM | 40MG | TABLET | Resolved | 2021-01-18 | 2021-03-09 | 131870 |
APO-QUINAPRIL | 40MG | TABLET | Actual shortage | 2021-03-15 | 2021-10-30 | 135695 |
APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-03-19 | 2021-05-03 | 136030 |
APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-04-09 | 2021-04-19 | 137267 |
APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2021-04-30 | 2021-05-25 | 138355 |
APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-05-25 | 2021-06-28 | 139851 |
APO-CITALOPRAM | 40MG | TABLET | Resolved | 2021-07-05 | 2021-07-26 | 141843 |
APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-08-16 | 2021-10-05 | 144204 |
APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2021-10-01 | 2021-10-20 | 146519 |
APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2021-10-01 | 2021-10-25 | 146522 |
APO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-11-22 | 2022-02-15 | 149708 |
APO-ATORVASTATIN | 40MG | TABLET | Avoided shortage | 2021-12-17 | 2022-01-18 | 151342 |
APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2022-01-21 | 2022-04-01 | 153262 |
APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-01-21 | 2022-03-14 | 153282 |
APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-01-28 | 2022-03-24 | 153786 |
APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2022-03-11 | 2022-03-25 | 156552 |
APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2022-03-25 | 2022-04-11 | 157329 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 | ||
APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 |